Dialysis of Drugs Guide

醫藥

免費 · App內購買 · 專為 iPad 設計。尚未針對 macOS 驗證。

The guidelines contained in this application are designed to provide extensive, easy-to-read information regarding the dialyzability of drugs. Numerous literature sources have been used in preparing the guidelines. For many drugs, including newly-approved medications, investigational agents and medications available in other countries, there have been no dialysis pharmacokinetic studies. In some cases, the available data may conflict. Conditions of dialysis used in published studies may not reflect current dialysis practice and technology. Variations in the duration of dialysis, blood and dialysate flow rates, dialysis membranes, and whether peritoneal dialysis is continuous or intermittent, will all affect drug removal. These guidelines distinguish between conventional hemodialysis and high permeability (high-flux) hemodialysis where such data are available. No information is provided on drug dialyzability with continuous renal replacement therapy (CRRT) or with plasmapheresis. For additional information on specific drugs, the reader should consult the primary literature. Users of this application are referred to www.renalpharmacyconsultants.com for background and explanatory material to assist in the interpretation of the tabular data. The website provides specific information about factors that influence drug dialyzability and special considerations, such as CRRT, plasmapheresis and drugs of abuse. Users must be familiar with this information prior to using the content of this application. The website also includes a table presenting sieving coefficient data from in vitro and in vivo evaluations, which can be used to predict dosing requirements in CRRT, and a table regarding removal of drugs of abuse. The app requires a one year auto-renewing subscription to access application data. It will auto-renew unless you cancel the subscription, which you can do at any time. Terms of Service: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/

評分與評論

  • 此 App 尚未收到足夠的評分或評論，無法顯示概覽。

2026 Data Update with links to comparison tables.

版本 1.90

開發者Renal Pharmacy Consultants, LLC指出App的隱私權實務可能包含下方描述的資料處理。如需更多資訊，請參閱 開發者的隱私權政策 。

  • 不收集資料

    開發者不會從這個 App 收集任何資料。

    依據你使用的功能或你的年齡等因素，隱私權實務可能有所不同。 更多內容

    輔助使用

    開發者尚未表示此 App 支援的輔助使用功能。 進一步瞭解

    資訊

    供應商
    • Renal Pharmacy Consultants LLC
    大小
    • 6.7 MB
    類別
    • 醫藥
    相容性
    需要 iOS 13.0 或以上版本。
    • iPhone
      需要 iOS 13.0 或以上版本。
    • iPad
      需要 iPadOS 13.0 或以上版本。
    • iPod touch
      需要 iOS 13.0 或以上版本。
    • Mac
      需要 macOS 11.0（或以上版本）以及配備 Apple M1（或以上版本）晶片的 Mac。
    • Apple Vision
      需要 visionOS 1.0 或以上版本。
    語言
    • 英文
    年齡分級
    16+
    App內購買
    是
    • One Year Account Subscription $690.00
    • One Year Subscription. $690.00
    • 進一步瞭解
    版權
    • © Renal Pharmacy Consultants, LLC
  • 隱私權政策

    • 你可能也會喜歡